OSL:MEDI - Euronext Oslo - NO0010159684 - Common Stock - Currency: NOK
OSL:MEDI (4/25/2025, 7:00:00 PM)
160
-3 (-1.84%)
The current stock price of MEDI.OL is 160 NOK. In the past month the price decreased by -13.28%. In the past year, price decreased by -8.57%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABL.DE | ABBOTT LABORATORIES | 26.78 | 195.04B | ||
IUI1.DE | INTUITIVE SURGICAL INC | 69.6 | 160.59B | ||
1ISRG.MI | INTUITIVE SURGICAL INC | 67.37 | 155.44B | ||
BSX.DE | BOSTON SCIENTIFIC CORP | 40.27 | 131.64B | ||
2M6.DE | MEDTRONIC PLC | 15.7 | 94.46B | ||
SHL.DE | SIEMENS HEALTHINEERS AG | 20.82 | 52.84B | ||
BOX.DE | BECTON DICKINSON AND CO | 14.61 | 51.31B | ||
EWL.DE | EDWARDS LIFESCIENCES CORP | 28.95 | 39.15B | ||
DC4.DE | DEXCOM INC | 43.32 | 24.63B | ||
PHI1.DE | KONINKLIJKE PHILIPS NV | 15.88 | 20.74B | ||
PHIA.AS | KONINKLIJKE PHILIPS NV | 15.87 | 20.74B | ||
BIM.PA | BIOMERIEUX | 29.92 | 13.67B |
Medistim ASA engages in the development, manufacture, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo and currently employs 154 full-time employees. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices that measure blood flow and visualize atherosclerosis, and thereby help improve the outcome of cardiac and vascular surgery. The firm provides Transit Time Flow Measurement (TTFM) and ultrasound imaging to the global market to enable medical professionals to reduce risk and enhance quality of cardiac, vascular and transplant surgery. Medistim’s activities are divided into two business units: Own Products Category and Third-Party Products Category. Furthermore, the Company has several subsidiaries, including Medistim USA Inc, Medistim Norge AS and Medistim Japan KK.
MEDISTIM ASA
Okernveien 94
Oslo OSLO NO
Employees: 154
Company Website: https://medistim.com/
Investor Relations: http://medistim.com/investor-relations/
Phone: 4723059660
The current stock price of MEDI.OL is 160 NOK. The price decreased by -1.84% in the last trading session.
The exchange symbol of MEDISTIM ASA is MEDI and it is listed on the Euronext Oslo exchange.
MEDI.OL stock is listed on the Euronext Oslo exchange.
9 analysts have analysed MEDI.OL and the average price target is 175.44 NOK. This implies a price increase of 9.65% is expected in the next year compared to the current price of 160. Check the MEDISTIM ASA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
MEDISTIM ASA (MEDI.OL) has a market capitalization of 2.93B NOK. This makes MEDI.OL a Mid Cap stock.
MEDISTIM ASA (MEDI.OL) currently has 154 employees.
MEDISTIM ASA (MEDI.OL) has a support level at 159.99 and a resistance level at 161.95. Check the full technical report for a detailed analysis of MEDI.OL support and resistance levels.
The Revenue of MEDISTIM ASA (MEDI.OL) is expected to grow by 8.3% in the next year. Check the estimates tab for more information on the MEDI.OL EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MEDISTIM ASA (MEDI.OL) has a dividend yield of 3.68%. The yearly dividend amount is currently 4.5. Check the full fundamental report for a detailed analysis of MEDI.OL dividend history, reliability and sustainability.
MEDISTIM ASA (MEDI.OL) will report earnings on 2025-05-09.
The PE ratio for MEDISTIM ASA (MEDI.OL) is 28.22. This is based on the reported non-GAAP earnings per share of 5.67 and the current share price of 160 NOK. Check the full fundamental report for a full analysis of the valuation metrics for MEDI.OL.
ChartMill assigns a technical rating of 2 / 10 to MEDI.OL. When comparing the yearly performance of all stocks, MEDI.OL turns out to be only a medium performer in the overall market: it outperformed 51.95% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to MEDI.OL. MEDI.OL scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
Over the last trailing twelve months MEDI.OL reported a non-GAAP Earnings per Share(EPS) of 5.67. The EPS decreased by -0.06% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 18.46% | ||
ROA | 18.06% | ||
ROE | 23.78% | ||
Debt/Equity | 0.06 |
ChartMill assigns a Buy % Consensus number of 42% to MEDI.OL. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 7.04% and a revenue growth 8.3% for MEDI.OL